Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 440 of 1,261
  1. US 10570115

    Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  2. US 10570128

    Agonists of the apelin receptor and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  3. US 10570124

    Deoxycytidine kinase binding compounds

    The Regents of the University of California · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  4. US 10570140

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  5. US 10569067

    Controlled release nanoparticulate matter delivery system

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  6. US 10568977

    Antibodies that bind activatable antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  7. US 10570091

    Method for producing pyrrole compound

    Takeda Pharmaceutical Company Limited · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  8. US 10568943

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  9. US 10568901

    Micro-RNA for the treatment of malignant solid tumors and metastasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  10. US 10568888

    Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  11. US 10568891

    Vaginal inserted estradiol pharmaceutical compositions and methods

    Compass Therapeutics LLC · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  12. US 10568898

    Lipophilic nanoparticles for drug delivery

    Northwestern University · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  13. US 10568913

    Method for generating mature β-like cells

    Healthregen PTY LTD · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  14. US 10568873

    Safranal-sorafenib combination therapy for liver cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  15. US 10568831

    Method to enhance swallowing safety and appeal of beverages for treating dysphagia based on rheological and sensory parameters

    Regents of the University of Minnesota · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  16. US 10568871

    Triazolone compounds and uses thereof

    TEMPEST THERAPEUTICS, INC. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  17. US 10568855

    Compositions and methods for enhancing the efficacy of contraceptive microbicides

    Evofem, Inc. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  18. US 10568863

    CPC distribution chromatography of cannabinoids

    BIONORICA ETHICS GMBH · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  19. US 10568828

    Peptide having hair growth-promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  20. US 10568877

    Preparation and anti-HSV-1 application of quinolinone derivatives

    OCEAN UNIVERSITY OF CHINA · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted
  21. US 10563204

    Methods of treating cancer harboring hemizygous loss of TP53

    The Board of Regents of the University of Texas System · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  22. US 10561763

    Oxygen generating biomaterial

    The Board of Regents of the University of Texas System · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  23. US 10562886

    Anti-cancer compounds

    The Regents of the University of California · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  24. US 10562884

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.